MIL-53 (((Fe) - 葡萄糖自组合复合物用于增强血管生成和内皮尖细胞激活
Jie Wu1,2, Leyi Liu1,2, Runze Li1,2
1Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, 510055, China.
Journal of nanobiotechnology
|June 19, 2025
概括
金属有机框架 (MOF) MIL-53 ((Fe) 纳米载体通过增强血管形成来促进骨再生. 这些纳米载体激活内皮细胞,促进血管生成,加速关键骨缺陷的修复.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 纳米技术 纳米技术
背景情况:
- 关键性骨缺陷带来了重大的临床挑战.
- 有效的骨再生需要强大的血管化.
- 金属有机框架 (MOFs) 是有前途的纳米载体用于治疗.
研究的目的:
- 为了研究MIL-53 ((Fe) MOF在骨再生相关的新血管化中的作用.
- 阐明MIL-53 (Fe) 对血管生成的影响背后的分子机制.
- 评估MIL-53 ((Fe) 作为骨缺陷修复的纳米载体.
主要方法:
- 合成和特征的MIL-53 ((Fe) 纳米载体.
- 评估MIL-53 ((Fe) 分散稳定性和生物相容性.
- 在体外评估内皮细胞激活和血管生成.
- 对Hippo/Yes相关蛋白 (YAP) 途径的研究.
主要成果:
- MIL-53 (Fe) 显示出出色的分散稳定性和生物相容性.
- MIL-53 (Fe) 显著增强了内皮尖细胞的激活和血管生成.
- MIL-53(Fe) @葡萄糖复合体增加了内皮细胞的糖分活性.
- 河马/YAP通路的激活与增强的尖端细胞表型有关.
结论:
- 在骨再生中,MIL-53 (Fe) 纳米载体有效促进新血管化.
- 通过Hippo/YAP通路增加内皮细胞的糖分活性,MIL-53 (Fe) 增强了血管生成.
- MIL-53 (Fe) 显示出作为修复关键骨缺陷的治疗策略的潜力.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Mechanism of Angiogenesis
5.9K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.9K


